- Investing Ideas
- /
- Global Undervalued Stocks Based On Cash Flows
Global Undervalued Stocks Based On Cash Flows
Results
901
0 new
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
901 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
OKEA | NOK 23.62 | -2.2% | -38.6% | NOK 2.5b | NOK 35.00 | PB3.2x | E73.7% | 0% | Energy | ||
FF | €8.62 | -1.1% | 6.8% | €211.0m | €12.25 | PB1.6x | E36.9% | 1.4% | Pharmaceuticals & Biotech | ||
PLSV | NOK 59.50 | -0.9% | n/a | NOK 10.1b | NOK 78.15 | PS5.5x | E49.3% | n/a | Energy | ||
CTT | SEK 265.00 | -5.4% | 22.1% | SEK 3.3b | n/a | PE32.6x | E24.8% | 2.0% | Capital Goods | ||
MEX | UK£0.54 | 0% | -33.7% | UK£20.9m | n/a | PB7.2x | E79.5% | n/a | Consumer Services | ||
5957 | JP¥544.00 | -9.5% | -7.8% | JP¥19.9b | JP¥690.00 | PE11.3x | E20.0% | 3.5% | Capital Goods | ||
ORDI | €5.70 | 0% | 49.8% | €513.1m | €5.75 | PE23.2x | E17.4% | 6.9% | Software | ||
NCC | UK£1.45 | -1.1% | 51.8% | UK£453.8m | UK£1.75 | PS1.4x | E89.1% | 3.2% | Software | ||
6415 | NT$417.00 | -1.0% | 36.5% | NT$160.3b | NT$411.07 | PE264.7x | E65.2% | 0.5% | Semiconductors | ||
HWM | US$94.87 | 15.2% | 96.9% | US$39.1b | US$97.90 | PE41.6x | E15.2% | 0.3% | Capital Goods | ||
TEN | zł86.05 | 4.1% | 7.6% | zł471.8m | zł95.21 | PE49.1x | E32.6% | 8.4% | Media | ||
AHR | US$16.07 | -2.7% | n/a | US$1.8b | US$15.71 | PB1.1x | E57.7% | 6.2% | Real Estate | ||
688319 | CN¥9.45 | 8.0% | -46.2% | CN¥3.8b | n/a | PS7.7x | E66.5% | 0.4% | Pharmaceuticals & Biotech | ||
6412 | NT$134.00 | 0% | 32.7% | NT$55.3b | NT$179.50 | PE15.8x | E27.2% | 4.5% | Capital Goods | ||
596 | HK$3.05 | 3.0% | 11.3% | HK$3.5b | HK$5.00 | PE15.9x | E38.0% | 1.0% | Software | ||
INSP | US$145.11 | 7.4% | -48.9% | US$4.2b | US$224.53 | PS6.5x | E53.1% | n/a | Healthcare | ||
300357 | CN¥19.32 | 4.2% | -47.3% | CN¥10.1b | CN¥29.46 | PE31.9x | E22.8% | 1.0% | Pharmaceuticals & Biotech | ||
301498 | CN¥43.52 | -1.1% | n/a | CN¥17.4b | CN¥60.33 | PE35.4x | E22.6% | 0.4% | Food, Beverage & Tobacco | ||
4373 | JP¥2,129.00 | -4.1% | -19.6% | JP¥124.1b | JP¥3,302.50 | PE20.3x | E20.2% | 2.3% | Software | ||
NAN | AU$3.15 | 5.0% | -34.2% | AU$954.4m | AU$3.33 | PE60.9x | E22.6% | n/a | Healthcare | ||
DOM | SEK 71.10 | -1.1% | -6.7% | SEK 22.7b | SEK 89.29 | PE19.3x | E26.8% | 2.7% | Automobiles | ||
FCCL | PK₨20.83 | -4.2% | 68.9% | PK₨51.1b | PK₨30.17 | PE6.8x | E26.0% | 0% | Materials | ||
3902 | JP¥490.00 | -8.9% | -25.9% | JP¥18.7b | JP¥710.00 | PE27.2x | E13.9% | 1.3% | Healthcare | ||
1801 | HK$39.25 | 0.9% | 19.7% | HK$63.9b | HK$55.92 | PS9.5x | E50.5% | n/a | Pharmaceuticals & Biotech |